LYNOZYFIC
Live / Registered — Registered (as of 17 Mar 2026)
What this means for you
Registered since 17 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97771269
- Registration number
- 8178821
- Mark type
- Stylized text
- Filed
- 27 Jan 2023
- Published for opposition
- 11 Apr 2023
- Registered
- 17 Mar 2026
- Attorney of record
- Terrence J. McAllister
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of oncological diseases and disorders
Owner
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
Prosecution history
- 17 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 20 Feb 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Feb 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Aug 2025 — USE AMENDMENT FILED
- 20 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 30 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 10 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 May 2025 — SOU EXTENSION 4 GRANTED
- 10 May 2025 — SOU EXTENSION 4 FILED
- 09 May 2025 — SOU TEAS EXTENSION RECEIVED